Insulet (PODD) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $149.83 +0.38%
Revenue Growth %: +17.9%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: +17.9%
Financial Fact:
Net loss: -3.08M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of $0.42, $0.10 better than the analyst estimate of $0.32. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $301.06 million.
GUIDANCE:
For the year ending December 31, 2022, the Company expects revenue growth in the range of 12% to 16%.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood shares fall on Q3 revenue miss even as EPS beats
- PPG Industries (PPG) Tops Q3 EPS by 12c ; Offers Guidance
- National Bank Holdings (NBHC) Misses Q3 EPS by 102c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
